tility of Homoeopathic medicines in atopic dermatitis and its impact in quality of life
Phase 2
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2024/05/067160
- Lead Sponsor
- ational Institute of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Individuals diagnosed with atopic dermatitis who meet the Diagnostic Criteria established by Hanifin and Rajka.
Patients of any gender, religious affiliation and socio-economic conditions.
Patients aged between 16 to 65 years.
Patients who are ready to provide written informed consent for participation in the study.
Exclusion Criteria
Individuals with diagnosed unstable mental or psychiatric conditions, severe systemic disorders, or life-threatening infections will be excluded from the study.
Patients currently undergoing treatment for Atopic Dermatitis with other therapies.
Pregnant and breastfeeding women, will also not be eligible for participation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eczema Area and Severity Index and ScoradTimepoint: Baseline & 6 months
- Secondary Outcome Measures
Name Time Method Dermatology Life Quality IndexTimepoint: Baseline & 6 months